Mathes Company’s Pfizer PFE Stock Holding History

Mathes Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.36M	Hold	48,623	–	–	0.5%	45
2025 Q4	$1.21M	Sell	48,623 -500	-1%	-$12.6K	0.43%	46
2025 Q3	$1.25M	Buy	49,123 +9,250	+23%	+$228K	0.45%	48
2025 Q2	$967K	Buy	39,873 +9,500	+31%	+$222K	0.36%	57
2025 Q1	$770K	Sell	30,373 -1,000	-3%	-$26.2K	0.31%	61
2024 Q4	$832K	Sell	31,373 -5,527	-15%	-$150K	0.3%	61
2024 Q3	$1.07M	Buy	36,900 +4,600	+14%	+$134K	0.38%	61
2024 Q2	$904K	Sell	32,300 -5,200	-14%	-$143K	0.33%	63
2024 Q1	$1.04M	Buy	37,500 +6,100	+19%	+$169K	0.39%	60
2023 Q4	$904K	Hold	31,400	–	–	0.37%	63
2023 Q3	$1.04M	Hold	31,400	–	–	0.48%	56
2023 Q2	$1.15M	Buy	+31,400	New	+$1.22M	0.5%	54
2022 Q4	$1.67M	Hold	32,650	–	–	0.84%	41
2022 Q3	$1.43M	Sell	32,650 -750	-2%	-$36.4K	0.8%	40
2022 Q2	$1.75M	Hold	33,400	–	–	0.85%	44
2022 Q1	$1.73M	Hold	33,400	–	–	0.67%	51
2021 Q4	$1.97M	Buy	33,400 +1,300	+4%	+$64.4K	0.67%	54
2021 Q3	$1.38M	Hold	32,100	–	–	0.51%	61
2021 Q2	$1.26M	Buy	32,100 +9,800	+44%	+$381K	0.45%	59
2021 Q1	$808K	Buy	22,300 +3,050	+16%	+$108K	0.31%	75
2020 Q4	$709K	Sell	19,250 -829	-4%	-$30.4K	0.29%	78
2020 Q3	$699K	Buy	20,079 +11,120	+124%	+$390K	0.33%	74
2020 Q2	$278K	Hold	8,959	–	–	0.14%	98
2020 Q1	$277K	Sell	8,959 -4,743	-35%	-$162K	0.18%	84
2019 Q4	$509K	Sell	13,702 -4,743	-26%	-$169K	0.24%	89
2019 Q3	$629K	Hold	18,445	–	–	0.32%	79
2019 Q2	$758K	Hold	18,445	–	–	0.4%	66
2019 Q1	$743K	Hold	18,445	–	–	0.38%	71
2018 Q4	$764K	Sell	18,445 -3,162	-15%	-$131K	0.48%	62
2018 Q3	$903K	Sell	21,607 -632	-3%	-$24.3K	0.42%	65
2018 Q2	$766K	Sell	22,239 -317	-1%	-$10.8K	0.37%	75
2018 Q1	$759K	Hold	22,556	–	–	0.35%	74
2017 Q4	$775K	Sell	22,556 -11,804	-34%	-$402K	0.35%	75
2017 Q3	$1.16M	Sell	34,360 -527	-2%	-$16.9K	0.55%	55
2017 Q2	$1.11M	Hold	34,887	–	–	0.53%	53
2017 Q1	$1.13M	Sell	34,887 -2,199	-6%	-$69.3K	0.6%	49
2016 Q4	$1.14M	Sell	37,086 -1,686	-4%	-$51.5K	0.63%	48
2016 Q3	$1.25M	Sell	38,772 -527	-1%	-$17.6K	0.71%	45
2016 Q2	$1.31M	Sell	39,299 -580	-1%	-$18.5K	0.77%	43
2016 Q1	$1.12M	Buy	39,879 +15,704	+65%	+$449K	0.67%	42
2015 Q4	$740K	Buy	24,175 +844	+4%	+$26.6K	0.42%	67
2015 Q3	$695K	Buy	23,331 +1,001	+4%	+$32.1K	0.46%	63
2015 Q2	$710K	Hold	22,330	–	–	0.38%	74
2015 Q1	$737K	Sell	22,330 -1,054	-5%	-$33.5K	0.38%	72
2014 Q4	$691K	Sell	23,384 -1,397	-6%	-$40.1K	0.36%	80
2014 Q3	$695K	Hold	24,781	–	–	0.35%	81
2014 Q2	$698K	Sell	24,781 -2,108	-8%	-$60.1K	0.35%	85
2014 Q1	$819K	Sell	26,889 -8,168	-23%	-$244K	0.44%	73
2013 Q4	$1.02M	Buy	+35,057	New	+$1.02M	0.55%	54

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mathes Company's PFE Position: Q1 2026 in Review

Mathes Company held its Pfizer (PFE) position steady in Q1 2026 at 48,623 shares worth $1.36M. The position accounts for 0.5% of the portfolio, ranked #45.

Mathes Company first reported a position in PFE in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.97M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Mathes Company held 48,623 shares of Pfizer worth $1.36M as of Q1 2026.
Mathes Company left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.5% of Mathes Company's portfolio in Q1 2026, its #45 holding.
Mathes Company first reported a position in Pfizer in Q4 2013 and has held it in 49 quarters since.
Mathes Company's Pfizer position peaked at $1.97M in Q4 2021.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mathes Company's 13F filing for Q1 2026, filed 8 May 2026.